Chelsea Mclaughlin, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5700 Darrow Rd, Suite 106, Hudson, OH 44236 Phone: 330-656-5911 |
Shannon Barnes, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 5700 Darrow Rd, Hudson, OH 44236 Phone: 216-290-2081 |
Mrs. Kristen Louise Dowdell, PA-C Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 1049 Scarlet Oak Dr Apt D, Hudson, OH 44236 Phone: 716-812-2722 |
David Summers, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 5700 Darrow Rd Ste 106, Hudson, OH 44236 Phone: 330-656-5911 |
Shervan Mohan, PA Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 5700 Darrow Rd Ste 106, Hudson, OH 44236 Phone: 330-528-3593 |
Raymond H Wawrowski, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 5700 Darrow Road, Suite 106, Hudson, OH 44236 Phone: 330-656-9304 |
Mr. Brandon Richard Allen Wire, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 5700 Darrow Rd, #106, Hudson, OH 44236 Phone: 330-656-5911 |
News Archive
Experts from the Universities of Bath and Seville have carried out a series of experiments with which, for the first time, they have been able to characterize the normal electrical activity in PC-3 prostate cancer cells in real time, with a resulting low-frequency electrical pattern between 0.1 and 10 Hertz.
Ticagrelor administered in the ambulance reduces ischaemic events 24 hours after primary percutaneous coronary intervention (PCI), according to findings from the ATLANTIC-H24 study presented for the first time today at ESC Congress.
An adverse upbringing often impairs people's circumstances and health in their adult years, especially for couples who have both had similar experiences.
Vertex Pharmaceuticals Incorporated announced that it has completed the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for telaprevir, Vertex's investigational treatment for people with hepatitis C.
ImaginAb, Inc. and BZL Biologics, LLC have concluded a sublicense of BZL's PSMA/huJ591 antibody technology for the field of diagnostic imaging for PET and SPECT. "ImaginAb is pleased to have completed this [sub]licensing agreement with BZL as we believe that huJ591 will form the basis of an excellent clinical product for the diagnosis and management of prostate cancer.
› Verified 4 days ago